EMA’s Adaptive Licensing Policy: Broad Enthusiasm, Sparse Details
This article was originally published in The Pink Sheet Daily
Executive Summary
Most European health care stakeholders agree that adaptive licensing will improve access and promote innovation, but are undecided which drugs would qualify.